Discover the Benefits of Semaglutide (Ozempic) for Weight Loss
Semaglutide has become one of the most prescribed medications in modern medicine — and for good reason. Under brand names like Ozempic and Wegovy, this once-weekly injection has transformed what is possible in medically supervised weight loss. If you have struggled with your weight despite diet and exercise, here is what you need to know about how semaglutide works, what the clinical evidence shows, and whether it may be right for you.
How Semaglutide Works: The GLP-1 Mechanism
Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. GLP-1 stands for glucagon-like peptide-1, a hormone that your gut releases naturally after you eat. It has several important effects: it signals your pancreas to produce insulin in response to rising blood sugar, it suppresses glucagon (which would otherwise raise blood sugar), and it slows the rate at which food leaves your stomach (gastric emptying). Most importantly for weight loss, GLP-1 acts on receptors in the hypothalamus and brainstem — areas of the brain that regulate hunger and satiety — reducing appetite and increasing the feeling of fullness.
Natural GLP-1 is broken down within minutes. Semaglutide is engineered to resist this rapid breakdown, remaining active for approximately one week after injection. This sustained activation of GLP-1 pathways produces consistent appetite suppression and metabolic benefits throughout the week.
What the Clinical Trials Show
The evidence for semaglutide in weight management is among the strongest ever seen for a pharmaceutical intervention. The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program enrolled thousands of adults across multiple countries. Key findings include:
In the STEP 1 trial, participants receiving semaglutide 2.4 mg weekly lost an average of 14.9 percent of their body weight over 68 weeks — compared to just 2.4 percent in the placebo group. That represents nearly 35 pounds of average weight loss for a 230-pound individual. More than 86 percent of patients on semaglutide lost at least 5 percent of body weight, and nearly 70 percent lost more than 10 percent.
Beyond the scale, semaglutide has been shown to improve blood pressure, reduce triglycerides, improve blood sugar control, decrease waist circumference, and significantly reduce the risk of major cardiovascular events in high-risk patients (as demonstrated in the SELECT trial).
Who Qualifies for Semaglutide
Wegovy (semaglutide 2.4 mg) is FDA-approved for adults with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher in the presence of at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea. Ozempic (semaglutide 0.5 mg to 2 mg) is FDA-approved for type 2 diabetes management, though it is widely used off-label for weight loss.
Semaglutide is not appropriate for everyone. It should be avoided in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. It is not recommended during pregnancy. Patients with a history of pancreatitis or severe gastrointestinal disorders should discuss risks carefully with their physician.
Expected Weight Loss
Results vary by individual, but most patients begin to notice appetite reduction within the first two to four weeks. Meaningful weight loss — five percent or more of body weight — typically becomes apparent between weeks eight and sixteen. The greatest rate of weight loss generally occurs in the first six months, with continued but slower progress through twelve to eighteen months. Many patients achieve fifteen to twenty percent total body weight loss with appropriate dosing and lifestyle support.
Dr. Bruice's Semaglutide Program
At Dr. Bruice's practices in Denver, Aspen, and St. Louis, semaglutide is integrated into a comprehensive weight management program — not simply prescribed in isolation. Dr. Bruice evaluates each patient's hormone levels, metabolic health, body composition, and lifestyle factors before recommending treatment. When hormonal imbalances such as thyroid dysfunction, low testosterone, or estrogen excess are identified, BHRT can be combined with semaglutide to optimize results and protect long-term metabolic health.
If you are ready to explore whether semaglutide is right for you, contact Kenton Bruice, M.D. today to schedule a comprehensive weight loss consultation. Real, lasting results begin with a personalized plan.